To view this email as a web page, click here.
 
Refined Prediction of MACE in Subclinical Atherosclerosis
New study finds that noninvasive assessment of CAD with CCTA may help reclassify risk for and predict MACE in asymptomatic atherosclerosis.
Read more
 
Hypertensive Kidney Disease: Perfect Target for Precision Medicine
H-CKD may soon be more than a "phenotype of convenience with little clinical utility." How will precision medicine hone diagnosis and treatment?
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.